Synopsis of recent research by authors named "HollyAnn R Jacobs"
- Hollyann R Jacobs' recent research primarily focuses on the dermatological and urological adverse effects associated with the use of elexacaftor/tezacaftor/ivacaftor (ELX-TEZ-IVA) in patients with cystic fibrosis (CF).
- One study highlighted that 19 patients experienced new or worsening acne after starting ELX-TEZ-IVA, which is significant given the drug's positive systemic effects on lung function and sweat chloride levels.
- Another study reported on a case series of 7 males who experienced testicular pain shortly after initiating the same therapy, marking a previously undocumented adverse effect that warrants further investigation.